Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

Regeneron Pharmaceuticals beat Wall Street estimates for second-quarter revenue and profit on Friday helped by robust demand ...

Regeneron topped Wall Street estimates for second-quarter results on Friday, on robust demand for its blockbuster eczema drug ...

Delays in the decision dates for high-dose Eylea are linked to issues at a Catalent-owned facility. Once these are resolved, ...

(REGN) on Friday reported second-quarter earnings of $1.39 billion. The Tarrytown, New York-based company said it ...

Following Android and iOS last week, the new Gemini logo is now available on the web. As a favicon, it’s not the easiest change to spot, but the four Google colors do help distinguish Gemini in ...

The biopharmaceutical industry is growing rapidly as a result of significant advancements in biotechnology and drug ...

Amazon, Google, and Samsung are all working on an exciting way to bring AI to smart homes – and Apple risks being left behind. Samsung is first to launch the new feature: the ability to use ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock has underperformed the medical sector and S&P 500 Index in this ...

Original "Superman" star Jack O'Halloran believes the superhero should restore the American way, contrasting with James Gunn's view of Superman as an immigrant story.

After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed nonprofit led by the genetic testing company’s co-founder, Anne Wojcicki, ...